To assess the functional impact of METTL3 in breast cancer, we next performed GO analysis of the DEG and the DSE of METTL3 knockdown in MCF10-A, MCF7 and MDA-MB-231 cell lines (Fig. 3D–F). The gene discussed is METTL3; the disease is breast carcinoma.